Walleye Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-311,712
| Closed | -$477K | – | 1847 |
|
|
2025
Q1 | $477K | Sell |
311,712
-407,185
| -57% | -$623K | ﹤0.01% | 1099 |
|
|
2024
Q4 | $1.78M | Buy |
+718,897
| New | +$1.78M | ﹤0.01% | 741 |
|
|
2023
Q4 | – | Sell |
-115,962
| Closed | -$794K | – | 2122 |
|
|
2023
Q3 | $794K | Sell |
115,962
-225,618
| -66% | -$1.55M | ﹤0.01% | 974 |
|
|
2023
Q2 | $3.54M | Buy |
341,580
+223,656
| +190% | +$2.32M | 0.01% | 373 |
|
|
2023
Q1 | $954K | Sell |
117,924
-301,160
| -72% | -$2.44M | 0.01% | 758 |
|
|
2022
Q4 | $6.6M | Buy |
419,084
+149,136
| +55% | +$2.35M | 0.12% | 204 |
|
|
2022
Q3 | $4.25M | Buy |
+269,948
| New | +$4.25M | 0.08% | 249 |
|
|
2022
Q1 | – | Sell |
-10,341
| Closed | -$150K | – | 2182 |
|
|
2021
Q4 | $150K | Buy |
+10,341
| New | +$150K | ﹤0.01% | 1515 |
|
|
2019
Q3 | – | Sell |
-55,000
| Closed | -$120K | – | 474 |
|
|
2019
Q2 | $120K | Buy |
+55,000
| New | +$120K | 0.01% | 220 |
|